Amy Garabedian
General Counsel at LAVA THERAPEUTICS N.V.
Net worth: 224 772 $ as of 30/03/2024
Profile
Amy Garabedian is currently the Secretary & General Counsel at LAVA Therapeutics NV since 2021.
Prior to this, she worked as an Attorney at Ballard Spahr LLP.
From 2015 to 2020, she worked as an Associate General Counsel at Spark Therapeutics, Inc. Ms. Garabedian has a graduate degree from Temple University (Pennsylvania) and Widener University Delaware Law School, and an undergraduate degree from The Pennsylvania State University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
LAVA THERAPEUTICS NV
0.26% | 27/02/2023 | 67,499 ( 0.26% ) | 224 772 $ | 30/03/2024 |
Amy Garabedian active positions
| Companies | Position | Start |
|---|---|---|
| LAVA THERAPEUTICS N.V. | General Counsel | 26/07/2021 |
Former positions of Amy Garabedian
| Companies | Position | End |
|---|---|---|
| SPARK THERAPEUTICS, INC. | Corporate Officer/Principal | 30/04/2020 |
Ballard Spahr LLP
 Ballard Spahr LLP Miscellaneous Commercial ServicesCommercial Services Ballard Spahr LLP provides legal services. It also provides counsel in litigation, business and finance, real estate, intellectual property, and public finance. The company was founded in 1885 and is headquartered in Philadelphia, PA. | General Counsel | - |
Training of Amy Garabedian
| Temple University (Pennsylvania) | Graduate Degree |
| The Pennsylvania State University | Undergraduate Degree |
| Widener University Delaware Law School | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| LAVA THERAPEUTICS N.V. | Health Technology |
| Private companies | 2 |
|---|---|
Ballard Spahr LLP
Ballard Spahr LLP Miscellaneous Commercial ServicesCommercial Services Ballard Spahr LLP provides legal services. It also provides counsel in litigation, business and finance, real estate, intellectual property, and public finance. The company was founded in 1885 and is headquartered in Philadelphia, PA. | Commercial Services |
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA. | Health Technology |
- Stock Market
- Insiders
- Amy Garabedian
